Number of the records: 1
hodnotenie a znižovanie rizika liekov
SYS d000073938 LBL 00000nz--a2200181n--4500 005 20250606222442.7 008 180101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 065 $a N04.452.871.758 065 $a N06.850.505.715.750 066 $a 01 $c 03 150 $a hodnotenie a znižovanie rizika liekov $x LJ $x OG $x ST $2 slo 450 $w v $a ETASU $2 slo 450 $w v $a prvky na uistenie bezpečného užívania liekov $2 slo 450 $w v $a REMS (stratégia hodnotenia a znižovania rizika) $2 slo 665 $a 2018 $2 eng 665 $a Risk Assessment (2009-2017) $2 eng 665 $a Risk Management (2008-2017) $2 eng 680 9-
$i Strategies required by the US Food and Drug Administration (FDA) Amendments Act of 2007 when a question exists as to whether the benefits of a drug outweigh its risks. These constitute a safety plan with several potential components, including a medication guide, a communication plan, elements to ensure safe use and an implementation system to help guide the prescribers, pharmacists and patients. $2 eng 750 -2
$a Risk Evaluation and Mitigation $2 eng 980 $x M
Number of the records: 1